Nxstage Medical, Inc. 350 Merrimack Street Lawrence,
MA 01843 United States - Map Phone: 978-687-4700 Website: http://www.nxstage.com
NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. The company operates in two segments, System One and In-Center. Its primary product, the NxStage System One, is a portable hemodialysis system used for home hemodialysis and a range of dialysis therapies for chronic home hemodialysis treatment, and the treatment of acute and chronic kidney failure and fluid overload. The NxStage System One comprises components, such as The NxStage Cycler, a compact portable electromechanical device; The NxStage Cartridge, a single-use integrated treatment cartridge; and premixed dialysate for hemodialysis applications. The company also sells a line of extracorporeal disposable products for use primarily for in-center dialysis treatments for patients with end-stage renal disease (ESRD); and needles and blood tubing sets primarily to dialysis clinics for the treatment of ESRD. NxStage Medical, Inc. markets its products primarily to dialysis clinics, nephrologists, and hospitals through distributors and sales representatives in the United States, Mexico, and Europe. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts. Key Statistics
| |
| Nxstage Medical, Inc.’s ISS Governance QuickScore as of Jun 1, 2013 is 3. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 5; Compensation: 4. | | Brought to you by Institutional Shareholder Services (ISS) |
| | Pay | Exercised | Mr. Jeffrey H. Burbank ,
51 Founder, Chief Exec. Officer, Pres and Director | 728.00K | 700.00K | Mr. Robert S. Brown ,
54 Chief Financial Officer, Principal Accounting Officer, Sr. VP and Treasurer | 400.00K | 0.00 | Ms. Winifred L. Swan Esq.,
49 Sr. VP, Gen. Counsel and Sec. | 382.00K | 366.00K | Mr. Joseph E. Turk Jr.,
45 Pres of North American Operations | 447.00K | 232.00K | Kristen K. Sheppard Esq.,
VP of Investor Relations | N/A | N/A |
|
| | Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|